Abstract P2-01-11: SentimagIC: A non-inferiority trial comparing super paramagnetic iron oxide vs. Tc99 and blue dye in the detection of axillary sentinel nodes in patients with early stage breast cancer

Authors

Mark A. Gittleman MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2-2017

Volume

77

Issue

4

Published In/Presented At

https://aacrjournals.org/cancerres/article/77/4_Supplement/P2-01-11/623496/Abstract-P2-01-11-SentimagIC-A-non-inferiority?searchresult=1

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery

Document Type

Article